169 filings
Page 6 of 9
8-K
y5p4gzofu44 9kv
26 Apr 21
Other Events
6:11am
8-K
8e3o7rrhvr3kr
24 Mar 21
Departure of Directors or Certain Officers
4:49pm
DEFA14A
vdnr 2ozojzsm
24 Mar 21
Additional proxy soliciting materials
4:45pm
S-8
i3zd3
10 Mar 21
Registration of securities for employees
5:01pm
8-K
vz2ue0id8ikqlfl
10 Mar 21
Harpoon Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update
4:11pm
8-K
b9wh0zh
11 Jan 21
Harpoon Therapeutics Announces Closing of Public Offering of Common Stock
4:18pm
8-K
5if5e c8nlo83q7yo
7 Jan 21
Harpoon Therapeutics Announces Pricing of Public Offering of Common Stock
4:20pm
424B5
k0yy j388dh9pyyjr
7 Jan 21
Prospectus supplement for primary offering
4:16pm
424B5
fpmpnegmji9i8mxw9
6 Jan 21
Prospectus supplement for primary offering
4:43pm
8-K
ow0kr6vekpcy
4 Jan 21
T Cell Engager for Treatment of Small Cell Lung Cancer and other
4:00pm
8-K
wbehvmbn
11 Dec 20
Other Events
5:06pm
8-K
rupax0td51c7
9 Dec 20
Harpoon Therapeutics Reports Clinical Progress Across All Four TriTACĀ® Pipeline Development Programs
4:52pm
8-K
mhhklmar4vf6nbhh
4 Nov 20
Harpoon Therapeutics Reports Third Quarter 2020 Financial Results and Provides Corporate Update
4:15pm
8-K
m0nek8a7qa
5 Aug 20
Harpoon Therapeutics Reports Second Quarter 2020 Financial Results and Provides Corporate Update
4:12pm
8-K
f9avi7koea im3
2 Jul 20
Departure of Directors or Certain Officers
9:17am